-
Ischemic stroke, it turns out that atrial fibrillation is also one of the culprits
Time of Update: 2022-01-08
So far, a large number of evidence-based medicine studies have shown that oral anticoagulants can effectively reduce the risk of stroke in 2/3 of patients with atrial fibrillation, and have been recommended by domestic and foreign guidelines .
-
Cardiovasc Diabetol: How is diabetes related to the type of atrial fibrillation?
Time of Update: 2022-01-07
Studies are included in the meta-analysis if they assess the longitudinal association between the likelihood of non-paroxysmal AF (and paroxysmal AF) in patients with diabetes and paroxysmal AFThe overall research results show that diabetes is closely related to non-paroxysmal atrial fibrillation, rather than paroxysmal atrial fibrillation .
-
Monitoring individual triggers can reduce atrial fibrillation episodes
Time of Update: 2022-01-05
Research results include:Patients who completed the individualized trigger study reported a lower frequency of atrial fibrillation episodes within four weeks after the test than those who tracked only AFib episodes .
-
Diseases of the digestive tract can also cause atrial fibrillation, which is rare in clinical practice.
Time of Update: 2021-12-29
A case report recently published in "Cureus Journal of Medical Science" introduced a case of paroxysmal atrial fibrillation caused by hiatal hernia.
Discussion Atrial fibrillation and hiatal hernia are both common clinical diseases and a type of gastro-heart syndrome .
-
Sanofi Metadragon receives new indication in China for the treatment of sinus rhythm with a history of atrial fibrillation
Time of Update: 2021-12-24
According to the press release, Maidarone is the only antiarrhythmic drug that has been proven to significantly reduce the risk of hospitalization or all-cause death in patients with atrial fibrillation, providing a long-term effective and safer treatment option for patients with atrial fibrillation .
-
Eur J Heart Fail: The relationship between dapagliflozin and atrial fibrillation in heart failure patients with reduced ejection fraction
Time of Update: 2021-12-04
Compared with placebo, dapagliflozin reduces the risk of HF deterioration, cardiovascular death and all-cause death in patients with and without AF, and improves the symptoms of patients .
-
Cardiovasc Diabetol: Miraculously, diabetic patients have the highest risk of atrial fibrillation
Time of Update: 2021-12-04
In the multivariate Cox regression analysis, using normal BMI as the control group, low body weight was associated with a significantly higher risk of atrial fibrillation (HR 1.
Low-weight type 2 diabetic patients have the highest risk of atrial fibrillation, while overweight patients have the lowest risk of atrial fibrillation.
-
EHJ: The incidence of stroke and mortality in patients with atrial fibrillation discovered for the first time increased dramatically within 1 year!
Time of Update: 2021-12-04
Heart failureFor patients with acute coronary syndrome (ACS) and the combined first detected atrial fibrillation (AF) 1-year prognosis, especially stroke incidence and mortality, from Copenhagen, Denmark Hospital vascular specialists internal medicine carried out research, The results were published in the European Heart Journal .
-
JAHA: Efficacy and safety analysis of NOAC and warfarin in patients with atrial fibrillation and aortic stenosis
Time of Update: 2021-12-03
Recently, the heart blood vessels published a research article on the disease areas authoritative magazine JAHA, the purpose of the study was to assess the effects of warfarin and NOAC with aortic stenosis in patients with AF thromboembolism and major bleeding .
-
Eur Heart J: Incidence, risk factors and death of atrial fibrillation in breast cancer patients
Time of Update: 2021-12-03
Recently, the heart blood vessels magazine field authority Eur Heart published a research article on J, the purpose of this study was to evaluate breast cancer patients nationwide AF incidence, risk factors and related mortality .
-
JAHA: Association of diabetes with atrial fibrillation phenotype and cardiac and nervous system comorbidities
Time of Update: 2021-12-02
The secondary outcome of the study is the heart (ie, hypertension, Complications of myocardial infarction and heart failure) and nervous system (ie, history of stroke and cognitive impairment) .
-
cerebral hemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF)
Time of Update: 2021-11-13
In the recent APACHE-AF study, researchers evaluated the ratio of non-fatal strokes or vascular deaths in patients receiving apishaban and avoiding anticoagulation therapy in order to design larger trials Provide a basis .
-
Diabetologia: the relationship between the use of hypoglycemic drugs in diabetic patients and new-onset atrial fibrillation
Time of Update: 2021-11-13
On multivariate analysis, high risk elderly men, heart failure, chronic kidney disease and anemia and related new onset AF independent diabetes medicine, the use of sulfonylureas and independently associated with a lower risk of atrial fibrillation contrast The use of metformin, GLP1 analogs, DPP4 inhibitors, or insulin is independently associated with a higher risk of atrial fibrillation.
-
De Nuo Electrophysiology introduces Navik 3D three-dimensional mapping system to build a new ecology for treatment of atrial fibrillation
Time of Update: 2021-11-05
This investment and cooperation aims to introduce APN Health’s core product, Navik 3D™ imaging and navigation system, into the Greater China market, in conjunction with the CardioPulse™ pulse ablation product independently developed by De Nuo Electrophysiology, to isolate and isolate the pulmonary veins of paroxysmal atrial fibrillation.
-
Eur J Endocrinol: The relationship between subclinical thyroid dysfunction and the incidence of cardiovascular events in patients with atrial fibrillation
Time of Update: 2021-11-02
Objective: To investigate the relationship between subclinical thyroid dysfunction and cardiovascular risk in patients with atrial fibrillation (AF) .
Subclinical hypothyroidism is not associated with increased cardiovascular risk in patients with atrial fibrillation .